Claus Kjaersgaard will join Smartfish AS as the new CEO on 2. May 2016. Claus has broad experience from different roles within clinical nutrition and consumer healthcare companies like Pronova BioPharma and GSK, and comes from the position as VP Consumer Healthcare at Pronova BioPharma. Claus has a strong track record and a broad international experience coupled with strong leadership skills.
Jens Nordahl, present CEO in Smartfish, who has played an instrumental role in transforming Smartfish into a well-positioned biotech company will stay in the company management team and take on a new role as Head of Consumer Nutrition. The management team also consists of Maria Öhlander, CSO, and Christel Kanli, CFO/COO.
“Smartfish is in a very exciting phase right now with important clinical studies ongoing. With Claus Kjaersgaard taking on the CEO role and Jens Nordahl focusing on the important Consumer business we will create a stronger management team and secure continuity and momentum” says Jon Risfelt, Chairman of the Board.
Smartfish is a Norwegian research company with offices in Oslo and Stockholm and focus on proprietary omega-3-based nutrition formulations. Smartfish presently conducts clinical trials in cancer and COPD patients with cachexia (muscle wasting) while building the commercial platform for evidence based medical, consumer and sports nutrition. Smartfish has been awarded BIA and Nano2021 grants from the Norwegian Research council for its breakthrough medical research programme. Norwegian Investinor and Swedish Industrifonden are the two major investors together with several private individuals. The company is located in Oslo Science Park.
Contact person Smartfish AS: Jon Risfelt, firstname.lastname@example.org, + 46 734 34 33 32
Contact person BASF: Laila Hopen Marmetschke, email@example.com, +45 40860530